Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection

Journal of Infection

Volumn 70, Issue 2, 2015, Pages 187-196

  Fox, Annette ^a,b,c   Mai, Le Quynh ^d   Thanh, Le Thi ^d   Wolbers, Marcel ^a,b   Le Khanh Hang, Nguyen ^d   Thai, Pham Quang ^d   Thu Yen, Nguyen Thi ^d   Minh Hoa, Le Nguyen ^a   Bryant, Juliet E ^a,b   Duong, Tran Nhu ^d   Thoang, Dang Dinh ^e   Barr, Ian G ^f   Wertheim, Heiman ^a,b   Farrar, Jeremy ^a,b   Hien, Nguyen Tran ^d   Horby, Peter ^a,b  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d National Institute of Hygiene and Epidemiology   (Viet Nam)

^e Ha Nam Centre for Preventive Medicine   (Viet Nam)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Antibody; Hemagglutination inhibition tests; Human; Humans; Humoral; Immunity; Influenza; Neutralizing; Pandemics

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; FEMALE; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; PANDEMIC INFLUENZA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; THROAT CULTURE; VIETNAMESE; ADOLESCENT; BLOOD; COHORT ANALYSIS; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY; VIET NAM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA, HUMAN; MALE; MIDDLE AGED; VIETNAM; YOUNG ADULT;

EID: 84921062118     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.09.003     Document Type: Article

References (56)

1. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000, 69:531-569. PubMed PMID: 10966468. Epub 2000/08/31. eng.
2. Edmondson W.P., Rothenberg R., White P.W., Gwaltney J.M. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge. Am J Epidemiol 1971 Jun, 93(6):480-486. PubMed PMID: 5562720. Epub 1971/06/01. eng.
3. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972 Dec, 70(4):767-777. PubMed PMID: 4509641. Pubmed Central PMCID: 2130285. Epub 1972/12/01. eng.
4. Evans A.S. Serologic studies of acute respiratory infections in military personnel. Yale J Biol Med 1975 Jul, 48(3):201-209. PubMed PMID: 169640. Pubmed Central PMCID: 2595222. Epub 1975/07/01. eng.
5. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br Med Bull 1979 Jan, 35(1):69-75. PubMed PMID: 367490. Epub 1979/01/01. eng.
6. Fox J.P., Cooney M.K., Hall C.E., Foy H.M. Influenza virus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982 Aug, 116(2):228-242. PubMed PMID: 7114034.
7. Clements M.L., Betts R.F., Tierney E.L., Murphy B.R. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986 Jul, 24(1):157-160. PubMed PMID: 3722363.
8. Coudeville L., Bailleux F., Riche B., Megas F., Andre P., Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol 2010, 10:18. PubMed PMID: 20210985. Pubmed Central PMCID: 2851702. Epub 2010/03/10. eng.
9. Gill P.W., Murphy A.M. Naturally acquired immunity to influenza type A: a further prospective study. Med J Aust 1977 Dec 3, 2(23):761-765. PubMed PMID: 611373.
10. Couch R.B., Kasel J.A. Immunity to influenza in man. Annu Rev Microbiol 1983, 37:529-549. PubMed PMID: 6357060.
11. Frank A.L., Taber L.H. Variation in frequency of natural reinfection with influenza A viruses. J Med Virol 1983, 12(1):17-23. PubMed PMID: 6619811. Epub 1983/01/01. eng.
12. Wu J.T., Ma E.S., Lee C.K., Chu D.K., Ho P.L., Shen A.L., et al. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis 2010 Nov 15, 51(10):1184-1191. PubMed PMID: 20964521. Pubmed Central PMCID: 3034199. Epub 2010/10/23. eng.
13. Xu C., Bai T., Iuliano A.D., Wang M., Yang L., Wen L., et al. The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One 2011, 6(4):e17919. PubMed PMID: 21533034. Pubmed Central PMCID: 3080876. Epub 2011/05/03. eng.
14. Chen H., Wang Y., Liu W., Zhang J., Dong B., Fan X., et al. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg Infect Dis 2009 Nov, 15(11):1849-1850. PubMed PMID: 19891883. Pubmed Central PMCID: 2857250. Epub 2009/11/07. eng.
15. Chen C.J., Lee P.I., Chang S.C., Huang Y.C., Chiu C.H., Hsieh Y.C., et al. Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS One 2011, 6(9):e24440. PubMed PMID: 21909433. Pubmed Central PMCID: 3164718. Epub 2011/09/13. eng.
16. Prachayangprecha S., Makkoch J., Payungporn S., Chieochansin T., Vuthitanachot C., Vuthitanachot V., et al. Serological analysis of human pandemic influenza (H1N1) in Thailand. J Health Popul Nutr 2010 Dec, 28(6):537-544. PubMed PMID: 21261198. Pubmed Central PMCID: 2995021. Epub 2011/01/26. eng.
17. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004 Jul 16, 305(5682):371-376. PubMed PMID: 15218094. Epub 2004/06/26. eng.
18. Hay A.J., Gregory V., Douglas A.R., Lin Y.P. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001 Dec 29, 356(1416):1861-1870. PubMed PMID: 11779385. Pubmed Central PMCID: 1088562. Epub 2002/01/10. eng.
19. Rambaut A., Pybus O.G., Nelson M.I., Viboud C., Taubenberger J.K., Holmes E.C. The genomic and epidemiological dynamics of human influenza A virus. Nature 2008 May 29, 453(7195):615-619. PubMed PMID: 18418375. Pubmed Central PMCID: 2441973. Epub 2008/04/18. eng.
20. Ferguson N.M., Galvani A.P., Bush R.M. Ecological and immunological determinants of influenza evolution. Nature 2003 Mar 27, 422(6930):428-433. PubMed PMID: 12660783. Epub 2003/03/28. eng.
21. Horby P., Mai le Q., Fox A., Thai P.Q., Thi Thu Yen N., Thanh le T., et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I. Am J Epidemiol 2012 May 15, 175(10):1062-1074. PubMed PMID: 22411862. Pubmed Central PMCID: 3353138. Epub 2012/03/14. eng.
22. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007 Nov 1, 23(21):2947-2948. PubMed PMID: 17846036. Epub 2007/09/12. eng.
23. Felsenstein J. PHYLIP (Phylogeny inference package) 2005, Department of Genome Sciences, University of Washington, Seattle. 3.6 ed.
24. Cauchemez S., Horby P., Fox A., Mai le Q., Thanh le T., Thai P.Q., et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 2012, 8(12):e1003061. PubMed PMID: 23271967. Pubmed Central PMCID: 3521724. Epub 2012/12/29. eng.
25. Meiklejohn G., Weiss D.L., Shragg R.I., Lennette E.H. Evaluation of monovalent influenza virus vaccines. I. Observations onantibody response following vaccination. Am J Hyg 1952 Jan, 55(1):1-11. PubMed PMID: 14885161. Epub 1952/01/01. eng.
26. Meiklejohn G., Kempe C.H., Thalman W.G., Lennette E.H. Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic. Am J Hyg 1952 Jan, 55(1):12-21. PubMed PMID: 14885162. Epub 1952/01/01. eng.
27. Dowdle W.R., Coleman M.T., Mostow S.R., Kaye H.S., Schoenbaum S.C. Inactivated influenza vaccines. 2. Laboratory indices of protection. Postgrad Med J 1973 Mar, 49(569):159-163. PubMed PMID: 4803439. Pubmed Central PMCID: 2495389. Epub 1973/03/01. eng.
28. Virelizier J.L. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 1975 Aug, 115(2):434-439. PubMed PMID: 807637. Epub 1975/08/01. eng.
29. McDonald J.C., Zuckerman A.J., Beare A.S., Tyrrell D.A. Trials of live influenza vaccine in the Royal Air Force. Br Med J 1962 Apr 14, 1(5284):1036-1042. PubMed PMID: 20789383. Pubmed Central PMCID: 1958186. Epub 1962/04/14. eng.
30. Hirota Y., Kaji M., Ide S., Kajiwara J., Kataoka K., Goto S., et al. Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness. Vaccine 1997 Jun, 15(9):962-967. PubMed PMID: 9261942. Epub 1997/06/01. eng.
31. Beare A.S., Hobson D., Reed S.E., Tyrrell D.A. A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet 1968 Aug 24, 2(7565):418-422. PubMed PMID: 4174153. Epub 1968/08/24. eng.
32. Edwards K.M., Dupont W.D., Westrich M.K., Plummer W.D., Palmer P.S., Wright P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994 Jan, 169(1):68-76. PubMed PMID: 8277200. Epub 1994/01/01. eng.
33. Belshe R.B., Gruber W.C., Mendelman P.M., Mehta H.B., Mahmood K., Reisinger K., et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis 2000 Mar, 181(3):1133-1137. PubMed PMID: 10720541.
34. Beyer W.E., Palache A.M., de Jong J.C., Osterhaus A.D. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 2002 Jan 31, 20(9-10):1340-1353. PubMed PMID: 11818152. Epub 2002/01/31. eng.
35. Lee M.S., Mahmood K., Adhikary L., August M.J., Cordova J., Cho I., et al. Measuring antibody responses to a live attenuated influenza vaccine in children. Pediatr Infect Dis J 2004 Sep, 23(9):852-856. PubMed PMID: 15361726. Epub 2004/09/14. eng.
36. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol January 1, 2007, 81(1):215-228.
37. Davies J.R., Grilli E.A. Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses. Epidemiol Infect 1989 Apr, 102(2):325-333. PubMed PMID: 2703026. Pubmed Central PMCID: 2249427. Epub 1989/04/01. eng.
38. Chen M.I., Lee V.J., Lim W.Y., Barr I.G., Lin R.T., Koh G.C., et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 2010 Apr 14, 303(14):1383-1391. PubMed PMID: 20388894. Epub 2010/04/15. eng.
39. Couch R.B., Atmar R.L., Franco L.M., Quarles J.M., Nino D., Wells J.M., et al. Prior infections with seasonal influenza A/H1N1 virus reduced the illness severity and epidemic intensity of pandemic H1N1 influenza in healthy adults. Clin Infect Dis 2012 Feb 1, 54(3):311-317. PubMed PMID: 22075792. Pubmed Central PMCID: 3258274. Epub 2011/11/15. eng.
40. Couch R.B., Atmar R.L., Franco L.M., Quarles J.M., Wells J., Arden N., et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis 2013 Mar 15, 207(6):974-981. PubMed PMID: 23307936. Pubmed Central PMCID: 3633450.
41. Cowling B.J., Ng S., Ma E.S., Cheng C.K., Wai W., Fang V.J., et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. Clin Infect Dis 2010 Dec 15, 51(12):1370-1379. PubMed PMID: 21067351. Epub 2010/11/12. eng.
42. Riley S., Kwok K.O., Wu K.M., Ning D.Y., Cowling B.J., Wu J.T., et al. Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study. PLoS Med 2011 Jun, 8(6):e1000442. PubMed PMID: 21713000. Pubmed Central PMCID: 3119689. Epub 2011/06/30. eng.
43. Kelly H., Peck H.A., Laurie K.L., Wu P., Nishiura H., Cowling B.J. The age-specific cumulative incidence of infection with pandemic influenza H1N1 2009 was similar in various countries prior to vaccination. PLoS One 2011, 6(8):e21828. PubMed PMID: 21850217. Pubmed Central PMCID: 3151238. Epub 2011/08/19. eng.
44. Defang G.N., Martin N.J., Burgess T.H., Millar E.V., Pecenka L.A., Danko J.R., et al. Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples. PLoS One 2012, 7(12):e48229. PubMed PMID: 23284613. Pubmed Central PMCID: 3527466.
45. Williams W.O., Hart R.J.C., Mann P.G., Pereira M.S., Smith J.W.G. Long-term study of influenza in families. J R Coll Gen Pract 1981 Jun, 31(227):351-356. PubMed PMID: 7299729. Pubmed Central PMCID: 1972026. Epub 1981/06/01. eng.
46. Carter D.M., Bloom C.E., Nascimento E.J., Marques E.T., Craigo J.K., Cherry J.L., et al. Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J Virol 2013 Feb, 87(3):1400-1410. PubMed PMID: 23115287. Pubmed Central PMCID: 3554183. Epub 2012/11/02. eng.
47. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009 Mar, 16(3):265-273. PubMed PMID: 19234466.
48. Wang T.T., Palese P. Universal epitopes of influenza virus hemagglutinins?. Nat Struct Mol Biol 2009 Mar, 16(3):233-234. PubMed PMID: 19234464. Epub 2009/02/24. eng.
49. Okuno Y., Matsumoto K., Isegawa Y., Ueda S. Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains. J Virol 1994 Jan, 68(1):517-520. PubMed PMID: 8254764.
50. Wang T.T., Tan G.S., Hai R., Pica N., Petersen E., Moran T.M., et al. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog 2010 Feb, 6(2):e1000796. PubMed PMID: 20195520. Pubmed Central PMCID: 2829068. Epub 2010/03/03. eng.
51. Kashyap A.K., Steel J., Oner A.F., Dillon M.A., Swale R.E., Wall K.M., et al. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U. S. A 2008 Apr 22, 105(16):5986-5991. PubMed PMID: 18413603.
52. Throsby M., van den Brink E., Jongeneelen M., Poon L.L., Alard P., Cornelissen L., et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 2008, 3(12):e3942. PubMed PMID: 19079604.
53. Wilson I.A., Cox N.J. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 1990, 8:737-771. PubMed PMID: 2188678. Epub 1990/01/01. eng.
54. Jegaskanda S., Job E.R., Kramski M., Laurie K., Isitman G., de Rose R., et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol 2013 Feb 15, 190(4):1837-1848. PubMed PMID: 23319732. Epub 2013/01/16. eng.
55. Belshe R.B., Gruber W.C., Mendelman P.M., Cho I., Reisinger K., Block S.L., et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb, 136(2):168-175. PubMed PMID: 10657821.
56. Goodwin K., Viboud C., Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006 Feb 20, 24(8):1159-1169. PubMed PMID: 16213065. Epub 2005/10/11. eng.